Investigation And Analysis On Cardiovascular Disease (CVD) Regimen And Discuss How To Make Make Full Use Of Clinical Pharmacists Resource

objective: 1By investigating the hospital inpatient and outpatient cardiovascular disease,cardiovascular specialist merger disease drug treatment,the rationality of the treatment and existing problems can be analyzed,in order to research and timely find for clinical pharmacists a solution to optimize treatment that serves patients better.2With investigation and analysis of the doctor's advice rationality directed at patient,combined with CVD,from a cardiovascular specialist,comparing the doctor's advice of cardiovascular specialist and non-cardiovascular specialist in the treatment of cardiovascular disease,through the above results,the meaning of cardiovascular clinical pharmacists on department transference can be judged,the significance of the necessity of general medicine and hospital development can be evaluated,the rational use of clinical pharmacists resources,at the same time,can also provide reference for other hospitals clinical pharmacists work mode.Methods :Through retrospective method,investigation from March 2014-December 2015,hospital doctor's advice and outpatient prescription directed at patients with cardiovascular disease can be investigated.The survey is practiced by using stratified sampling and equidistant sampling,namely the outpatients and inpatients sampling respectively.Monthly 100 prescriptions for outpatients extracted randomly from 2200 ones can be reviewed;hospitalized patients can be subdivided into segments for cardiovascular diseases and non-CVD.Cardiovascular disease department monthly extract 20 disease records concerned with cardiovascular disease amounting to 500,while non-cardiovascular department monthly extract 10 records,a total of 220 cardiovascular disease,excluding merger tumors,transfer,Go to Another Hospital,automatic discharge,non-cardiovascular disease and medical records on death in hospital.Collecting gender of hospitalized patients,age,name,name of cardiovascular disease,name of cardiovascular disease merged,medical advice article number,unreasonable type of ones,problems exited and unreasonable type of prescription gathered from outpatients,problems concerned,RASS blocker usage,antiplatelet drug's usage,make using of Excel software and SPSS software data can be statistically analyzed.Results: 467 patients from cardiovascular diseases department were selected,the advice numbers of 8706 reviewed include262 number belong to the unreasonable.In the above numbers,120 of5808 numbers belonging to cardiovascular diseases are the unreasonable doctor's advises(2.07%),142 articles of 2898 non-cardiovascular disease's advice is not reasonable,148(4.90%).Cardiovascular patients' age,number of disease,the doctor's advice ‘ s number,unreasonable number make some correlation.the most from cardiovascular department are patients with high blood pressure,accounted for 26.62% of all cardiovascular disease;of the Cardiovascular department merger disease AECOPD is on top,accounted for 14.56% of all merge disease.For 220 cases collected for the non-cardiovascular department,996 articles reviewed for cardiovascular disease included 90 numbers of unreasonable medical advices.Prescriptions of outpatient's selective examination on cardiovascular disease have 2200 articles,unreasonable number have 78,accounting for 3.55% of the spot check's numbers.Second:The usage rate of warfarin for non-valvular atrial is low,which is 27.27% and patients older than 75 years old is lower,only 0%.Compared with aspirin,Clopidogrel has a higher usage rate and compared with ARB,ACEI has a lower usage rate.Third:For treatment of cardiovascular disease for Cardiovascular department and non-cardiovascular one,both unreasonable rate is on significant differences(P < 0.05)while unreasonable rate of doctor advices for cardiovascular department,compared with merger disease's ones,have significant difference(P <0.05).Conclusion:First:Cardiovascular clinical pharmacists should focus on old patients who have more disease,should master cardiovascular specialist common complications ' s treatment options and clinical pharmacists' s effection should be used at the treat beginning.Every day,outpatient service prescription should be review by clinical pharmacists and feedback of unreasonable prescription should be given to doctor in time,all of this is to improve the drug use rationality.Second:Warfarin is better than antiplatelet drugs,clinical pharmacists should join in anticoagulation treatment of warfarin.Clopidogrel secondary prevention programs should be studied further.Third:In order to make full use of clinical pharmacists resource and better to develop general clinical pharmacists,the clinical pharmacists rotation system is worth carrying out.